Watch PRPH. Know when insiders buy.
One email the day a filing lands. Free.
PRPH
ProPhase Labs, Inc.
0.01
+0.00 +0.00%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $156KP/E —DIV YIELD —FCF YIELD —REV TTM $3.8M −31.2%NET INCOME −$22.5MNET DEBT $1.6M52W 0.01 – 6.10SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1M | −18.9% | 22.4% | −$2.6M | −$3.1M | — | -0.22 | −$78K | — | — | Aug 19 |
| Q1 2026 · Mar 31 | $1.2M | −18.3% | 25.2% | −$2.4M | −$5.2M | −230.5% | -0.42 | −$748K | — | — | Jul 9 |
| Q4 2025 · Dec 31derived | $784K | −47.5% | 31.5% | −$5.7M | −$7.4M | — | -1.55 | −$1.2M | $0 | −$1.2M | Jun 1 |
| Q3 2025 · Sep 30 | $883K | −37.6% | -13.9% | −$4.8M | −$6.8M | — | -0.16 | −$3.5M | $0 | −$3.5M | Nov 19 |
| Q2 2025 · Jun 30 | $1.2M | −17.1% | 58.9% | −$3.9M | −$4.5M | — | -1.08 | −$247K | $0 | −$247K | Aug 19 |
| Q1 2025 · Mar 31 | $1.4M | −39.3% | 36.8% | −$3.7M | $4M | — | 1.13 | −$3.4M | $0 | −$3.4M | Jul 9 |
| Q4 2024 · Dec 31derived | $1.5M | — | -10.0% | −$17.3M | −$34.4M | — | -25.66 | −$3.5M | $40K | −$3.6M | Jun 1 |
| Q3 2024 · Sep 30 | $1.4M | −83.1% | 15.2% | −$6.5M | −$6.6M | — | -0.35 | −$4M | −$1K | −$4M | Nov 19 |
| Q2 2024 · Jun 30 | $1.5M | — | -10.3% | −$7.2M | −$6.2M | — | -0.33 | −$4.8M | $0 | −$4.8M | Aug 13 |
| Q1 2024 · Mar 31 | $2.4M | — | -2.5% | −$7.6M | −$6.3M | — | -0.36 | −$5.1M | $867K | −$6M | May 20 |
| Q4 2023 · Dec 31derived | −$5.9M | — | 63.4% | −$11M | −$8.8M | — | -0.51 | −$753K | $239K | −$992K | Apr 1 |
| Q3 2023 · Sep 30 | $8.4M | — | 27.8% | −$6.5M | −$5.1M | — | -0.30 | −$4.7M | $668K | −$5.3M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $4.3M | 31.9% | −$18M | −$14.7M | -339.3% | -1.74 | −$8.3M | $0 | −$8.3M | — | — |
| FY2024 · to Dec 31 | $6.8M | -2.2% | −$38.6M | −$53.4M | -788.2% | -26.68 | −$17.5M | $906K | −$18.4M | $0 | — |
| FY2023 · to Dec 31 | $35M | 44.5% | −$21.2M | −$16.8M | -48.0% | -0.98 | −$11.9M | $2.1M | −$14M | $588K | $0 |
| FY2022 · to Dec 31 | $122.6M | 57.6% | $23.6M | $18.5M | 15.1% | 1.02 | $28.6M | $3.9M | $24.6M | $2.2M | $9.4M |
| FY2021 · to Dec 31 | $79M | 53.1% | $9.8M | $6.3M | 7.9% | 0.40 | −$13.6M | $4.2M | −$17.9M | $917K | $4.5M |
| FY2020 · to Dec 31 | $14.5M | 31.7% | −$2.1M | −$2.1M | -14.6% | -0.18 | −$2.6M | $1.7M | −$4.3M | — | — |
Every number comes from ProPhase Labs, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.